Perceive Biotherapeutics
CompanyUnited States
Perceive Biotherapeutics develops one asset, in phase 2 (VOY-101 in geographic atrophy). Mostly gene therapy; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 2
- 0
- Trials
- 1
- Signal
Pipeline
1Phase 2, Gene therapy, geographic atrophy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Signals1
- Similar companies6